TY - JOUR
T1 - Catabolism of adenine nucleotides in adenosine deaminase deficient erythrocytes
AU - Mills, Gordon C.
AU - Goldblum, Randall M.
AU - Schmalstieg, Frank C.
N1 - Funding Information:
The authors acknowledge the technical assistance of K.B. Trimmer, K.E. Newkirk and R.J. Koolkin in portions of the study; also contributions of Dr. A.S. Goldman in securing blood specimens from patients. This work was supported in part by the following: NIH Grant No. DHEW RR-00073-14, General Clinical Research Centers Branch, Division of Research Facilities and Resources; and a grant from The National Foundation-March of Dimes No. 6-130.
PY - 1981/10/26
Y1 - 1981/10/26
N2 - In vitro incubation studies using fluoride and iodoacetate as glycolytic inhibitors have been carried out on red cells of the two subjects with adenosine deaminase deficiency. For comparison, similar studies have also been carried out on red cells from a normal subject and from a child with severe combined immunodeficiency with normal adenosine deaminase activity. The adenosine formed in the adenosine deaminase deficient red cells is a measure of adenosine 5′-phosphate breakdown initiated by 5′-nucleotidase, whereas inosine 5′-phosphate, inosine and hypoxanthine formation is a measure of adenosine 5′-phosphate breakdown initiated by adenylate deaminase. With fluoride as inhibitor, nearly all of the adenosine 5′-phosphate breakdown proceeded by way of adenylate deaminase, while with iodoacetate as inhibitor, 20-30% of the adenosine 5′-phosphate breakdown was initiated by 5′-nucleotidase acting on adenosine 5′-phosphate. In addition, significant amounts of adenine were produced in adenosine deaminase deficient red cells in the presence of the glycolytic inhibitors. Possible explanations for the findings noted in this study are discussed and related to recent studies on the properties of the pertinent purine nucleotide catabolic enzymes.
AB - In vitro incubation studies using fluoride and iodoacetate as glycolytic inhibitors have been carried out on red cells of the two subjects with adenosine deaminase deficiency. For comparison, similar studies have also been carried out on red cells from a normal subject and from a child with severe combined immunodeficiency with normal adenosine deaminase activity. The adenosine formed in the adenosine deaminase deficient red cells is a measure of adenosine 5′-phosphate breakdown initiated by 5′-nucleotidase, whereas inosine 5′-phosphate, inosine and hypoxanthine formation is a measure of adenosine 5′-phosphate breakdown initiated by adenylate deaminase. With fluoride as inhibitor, nearly all of the adenosine 5′-phosphate breakdown proceeded by way of adenylate deaminase, while with iodoacetate as inhibitor, 20-30% of the adenosine 5′-phosphate breakdown was initiated by 5′-nucleotidase acting on adenosine 5′-phosphate. In addition, significant amounts of adenine were produced in adenosine deaminase deficient red cells in the presence of the glycolytic inhibitors. Possible explanations for the findings noted in this study are discussed and related to recent studies on the properties of the pertinent purine nucleotide catabolic enzymes.
UR - http://www.scopus.com/inward/record.url?scp=0019802062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019802062&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(81)90193-4
DO - 10.1016/0024-3205(81)90193-4
M3 - Article
C2 - 7300574
AN - SCOPUS:0019802062
SN - 0024-3205
VL - 29
SP - 1811
EP - 1820
JO - Life Sciences
JF - Life Sciences
IS - 17
ER -